Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001949634 | SCV002238396 | pathogenic | Autosomal recessive polycystic kidney disease | 2022-09-14 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PKHD1 protein function. ClinVar contains an entry for this variant (Variation ID: 1458985). This missense change has been observed in individual(s) with polycystic kidney disease (PMID: 12506140). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 703 of the PKHD1 protein (p.Asp703Asn). |
Baylor Genetics | RCV004571747 | SCV005056296 | pathogenic | Polycystic kidney disease 4 | 2024-03-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV004785416 | SCV005401238 | likely pathogenic | not provided | 2024-05-16 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 12506140, 35065907, 34327338) |